Figure 3.
The percentage of participants retained in depot naltrexone treatment (continued to take scheduled depot naltrexone injections; top panel) and the therapeutic workplace (continued attending the workplace; bottom panel) across study weeks.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.